Home > Healthcare & Medical Devices > Vital Sign Monitoring Systems Market
Vital Sign Monitoring Systems Market Size is anticipated to observe notable traction between 2022 and 2028 on account of the rising advancements in medical tourism and growing preference for personalized healthcare. The expanding geriatric patient base and increasing threat of lifestyle-associated chronic disorders have escalated the penetration of medical insurance. Growing consumer awareness, technical progressions, and surging need for early diagnosis of these medical conditions in patients will foster market development.
Vital sign monitoring systems market or devices are valuable tools that provide information to medical and nursing staff regarding the physiologic condition of patients. The dearth of awareness regarding the devices, particularly in low- and middle-income countries may restrict the industry growth. However, the increasing number of hospitals coupled with rising popularity of home healthcare services will favor the market dynamics.
In terms of products, the industry remuneration from BP (blood pressure) monitoring devices will expand with rising instances of hypertension. According to the Centers for Disease Control and Prevention (CDC), around 116 million adults in the U.S. suffer from hypertension. The expanding geriatric population base along with the growing burden of lifestyle diseases, like obesity and diabetes, has led to the surging awareness of blood pressure checks. Owing to this, wireless BP monitoring systems are witnessing higher popularity as a useful tool for users for measuring and managing their daily blood pressure values. The increasing popularity of self-operational, mobile-based, and digital devices, as well as home-use BP monitors, will drive the market growth.
Based on end-use, the vital sign monitoring systems market size from hospitals will grow with the expanding patient pool in these settings. The devices are extensively utilized for periodically measuring basic physiologic parameters, like noninvasive blood pressure (NIBP), pulse rate, oxygen saturation (SpO2), and temperature in hospitals. They mark widespread presence in low-acuity areas, such as surgical and medical floors, and emergency department triage, for tracking the status of multiple low-acuity patients. Furthermore, the escalating financing spending for these devices will additionally fuel the product demand.
Geographically, North America vital sign monitoring systems market is poised to depict momentous growth through 2028. This is owing to the presence of a huge elderly population as well as high-end technology providers and well-established R&D facilities. The higher prevalence of interminable and lifestyle disorders, including infectious & respiratory diseases, diabetes, and hypertension has led to the growing adoption of remote and wireless devices. The rising number of new product launches led by the regional industry participants and the higher availability of streamlined coverage and favorable reimbursement policies will favor the market expansion.
Key suppliers and manufacturers of vital sign monitoring devices are working on inorganic strategic measures, like acquisitions, partnerships, R&D investments, and innovations for sustaining competition whilst expanding their global presence.
For instance, in February 2021, Royal Philips introduced its new portable monitoring kit, Philips Medical Tablet, to expand its remote patient management portfolio. The device is deployed with IntelliVue XDS software to offer clinicians critical patient data, including vital signs and clinical decision support.
GE Healthcare (General Electric), Masimo Corporation, CONTEC MEDICAL SYSTEMS CO., LTD., Medtronic plc, Boston Scientific Corporation, Nihon Kohden Corporation, A&D Company, Limited, OMRON Corporation, and Nonin Medical Inc. are some other leading players.
Amid the coronavirus crisis, the utility of vital sign monitoring systems market significantly surged up driven by the escalating infection count and the subsequent need for the continuous measurement of vital signs, including respiration & pulse rate, and temperature. This paved the path for numerous growth opportunities for market players. The growing adoption of sensor-based vital signs monitors for the inspection of infected patients during home isolation also contributed to amplified market revenue sales.
Market, by product
Market, by end-use
The above information is provided for the following regions and countries: